We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

115 hedge funds and large institutions have $775M invested in NxStage Medical Inc. in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

934% more call options, than puts

Call options by funds: $4.98M | Put options by funds: $482K

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

10% more capital invested

Capital invested by funds: $701M → $775M (+$73.5M)

1% more funds holding

Funds holding: 114115 (+1)

20% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 41

Holders
115
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
3.31%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.2%
New
21
Increased
33
Reduced
41
Closed
19
Calls
$4.98M
Puts
$482K
Net Calls
+$4.5M
Net Calls Change
+$2.35M

NXTM Hedge Fund Activity: Q2 2014 in Review

115 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2014, worth a combined $775M — up 10% from $701M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NXTM positions and 19 closed out — a net gain of 2 holders — while 33 added to existing stakes and 41 trimmed.

The largest buyer was RS Investment Management, opening a new position worth an estimated $22.4M. The largest seller was Massachusetts Financial Services, cutting an estimated $19.7M.

  • 115 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2014, up from 114 in Q1 2014.
  • Funds reported $775M of NxStage Medical Inc. stock for Q2 2014, up 10% quarter-over-quarter.
  • 21 funds opened new NxStage Medical Inc. positions in Q2 2014 and 19 closed out, a net change of +2 holders.
  • The largest NxStage Medical Inc. buyer in Q2 2014 was RS Investment Management, an estimated $22.4M added.
  • The largest NxStage Medical Inc. seller in Q2 2014 was Massachusetts Financial Services, an estimated $19.7M sold.

Based on aggregated 13F filings for Q2 2014.